Osseointegration of dental implants in patients undergoing bisphosphonate treatment: A literature review

Journal of Periodontology

Volumn 81, Issue 4, 2010, Pages 479-484

  Javed, Fawad ^a   Almas, Khalid ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Bisphosphonates; Dental implants; Oral; Osseointegration; Osteonecrosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

BONE REGENERATION; CASE CONTROL STUDY; DENTAL SURGERY; DRUG EFFECT; HUMAN; REVIEW; TOOTH IMPLANTATION;

BONE DENSITY CONSERVATION AGENTS; CASE-CONTROL STUDIES; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DENTAL RESTORATION FAILURE; DIPHOSPHONATES; HUMANS; OSSEOINTEGRATION;

EID: 77950666783     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.090587     Document Type: Review

References (35)

1. Green JR. Bisphosphonates: Preclinical review. Oncologist 2004;9(Suppl. 4):3-13.
2. Frith JC, Mönkkönen J, Blackburn GM, Russell RG, Rogers MJ. Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosire 5′-(beta, gamma-dichloromethylene) triphos-phate, by mammalian cells in vitro. J Bone Miner Res 1997;12:1358-1367.
3. Tenenbaum HC, Shelemay A, Girard B, Zohar R, Fritz PC. Bisphosphonates and periodontics: Potential applications for regulation of bone mass in the periodon-tium and other therapeutic/diagnostic uses. J Periodontol 2002;73:813-822.
4. Fleisch H. Bisphosphonates: Mechanisms of action. Endocr Rev 1998;19:80-100.
5. Reszka AA, Rodan GA. Mechanism of action of bisphosphonates. Curr Osteoporos Rep 2003;1:45-52.
6. Otomo-Corgel J. Implants and oral bisphosphonates: Risky business? J Periodontol 2007;78:373-376.
7. Vahtsevanos K, Kyrgidis A, Verrou E, et al. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol 2009;27:5356-5362.
8. Bilezikian JP. Osteonecrosis of the jaw - Do bisphosph-onates pose a risk? N Engl J Med 2006;355:2278-2281.
9. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetro-sis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005;63:1567-1575.
10. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007;65:369-376.
11. Mavrokokki T], Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 2007; 65:415-423.
12. American Dental Association Council for Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy: Expert panel recommendations. J Am Dent Assoc 2006;137:1144-1150.
13. Hewitt C, Farah CS. Bisphosphonate-related osteonecrosis of the jaws: A comprehensive review. J Oral Pathol Med 2007;36:319-328.
14. Javed F, Romanos GE. Impact of diabetes mellitus and glycemic control on the osseointegration of dental implants. A systematic literature review. J Periodontol 2009;80:1719-1730.
15. Wang HL, Weber D, McCauley LK. Effect of long-term oral bisphosphonates on implant wound healing: Literature review and a case report. J Periodontol 2007; 78:584-594.
16. Becker W, Hujoel PP, Becker BE, Willingham H. Osteoporosis and implant failure: An exploratory case-control study. J Periodontol 2000;71:625-631.
17. Starck WJ, Epker BN. Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: A case report. Int J Oral Maxillofac Implants 1995;10:74-78.
18. Goss A, Bartold M, Sambrook P, Hawker P. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series. J Oral Maxillofac Surg 2010; 68:337-343.
19. Sambrook P, Olver I, Goss A. Bisphosphonates and osteonecrosis of the jaw. Aust Fam Physician 2006; 35:801-803.
20. Pirih FQ, Zablotsky M, Cordell K, McCauley LK. Case report of implant placement in a patient with Paget's disease on bisphosphonate therapy. J Mich Dent Assoc 2009;91:38-43.
21. Torres J, Tamimi F, Garcia I, et al. Dental implants in a patient with Paget disease under bisphosphonate treatment: A case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;107:387-392.
22. Kasai T, Pogrel MA, Hossaini M. The prognosis for dental implants placed in patients taking oral bisphosphonates. J Calif Dent Assoc 2009;37:39-42.
23. Shirota T, Nakamura A, Matsui Y, Hatori M, Nakamura M, Shintani S. Bisphosphonate-related osteonecrosis of the jaw around dental implants in the maxilla: Report of a case. Clin Oral Implants Res 2009;20: 1402-1408.
24. Bell BM, Bell RE. Oral bisphosphonates and dental implants: A retrospective study. J Oral Maxillofac Surg 2008;66:1022-1024.
25. Grant BT, Amenedo C, Freeman K, Kraut RA. Outcomes of placing dental implants in patients taking oral bisphosphonates: A review of 115 cases. J Oral Maxillofac Surg 2008;66:223-230.
26. Ferrari S, Bianchi B, Savi A, et al. Fibula free flap with endosseous implants for reconstructing a resected mandible in bisphosphonate osteonecrosis. J Oral Maxillofac Surg 2008;66:999-1003.
27. Fugazzotto PA, Lightfoot WS, Jaffin R, Kumar A. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: Postoperative healing, early follow-up, and the incidence of complications in two private practices. J Periodontol 2007;78:1664-1669.
28. Brooks JK, Gilson AJ, Sindler AJ, Ashman SG, Schwartz KG, Nikitakis NG. Osteonecrosis of the jaws associated with use of risedronate: Report of 2 new cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:780-786.
29. Jeffcoat MK. Safety of oral bisphosphonates: Controlled studies on alveolar bone. Int J Oral Maxillofac Implants 2006;21:349-353.
30. Melo MD, Obeid G. Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy. J Can Dent Assoc 2005;71:111-113.
31. Estilo CL, Van Poznak CH, Wiliams T, et al. Osteone-crosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy. Oncologist 2008;13:911-920.
32. Reginster JY. Treatment of bone in elderly subjects: Calcium, vitamin D, fluor, bisphosphonates, calcitonin. Horm Res 1995;43:83-88.
33. McClung MR. Bisphosphonates. Endocrinol Metab Clin North Am 2003;32:253-271.
34. Marx RE, Cillo JE Jr, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 2007;65:2397-2410.
35. Crawford BS, McNulty RM, Kraut EH, Turowski RC. Extended use of intravenous bisphosphonate therapy for the prevention of skeletal complications in patients with cancer. Cancer Invest 2009;27:984-988.